Clinical Trial Update: Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a regimen of paclitaxel, carboplatin, and oral etoposide followed by weekly paclitaxel in high-grade neuroendocrine carcinoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• oral etoposide (etoposide (oral))

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Neuroendocrine Carcinoma | Phase 2 | Status: COMPLETED